Want to see IN:IOLCP full AI Analyst Report?
IOLCP Stock Chart & Stats
₹84.09
-₹4.90(-1.13%)
At close: 4:00 PM EST
₹84.09
-₹4.90(-1.13%)
Day’s Range― - ―
52-Week Range₹67.14 - ₹151.05
Previous CloseN/A
Volume410.76K
Average Volume (3M)113.78K
Market Cap
₹41.99B
Enterprise Value₹36.09B
Total Cash (Recent Filing)₹1.79B
Total Debt (Recent Filing)₹1.59B
Price to Earnings (P/E)32.0
Beta1.66
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.97%
Share Statistics
EPS (TTM)3.95
Shares Outstanding293,527,500
10 Day Avg. Volume248,884
30 Day Avg. Volume113,785
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)1.19
Price to Sales (P/S)0.92
P/FCF Ratio55.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.7
Revenue Forecast (FY)₹26.48B
Bulls Say, Bears Say
Bulls Say
Low Leverage & Growing EquityA very low debt-to-equity ratio and a materially larger equity base support financial resilience and provide capacity to invest or weather downturns. This durable capital structure lowers refinancing risk and strengthens the company's ability to fund capex or strategic initiatives over multiple years.
Diversified Chemicals & Pharma MixOperating across pharmaceuticals (APIs) and specialty chemicals provides structural diversification of revenue drivers and end markets. This mix moderates cyclical exposure, allows cross-segment resource allocation, and supports longer-term stability as different end markets recover at different paces.
Sustained Operating Profitability (EBIT/EBITDA)Despite headline margin pressure, the company still generates meaningful operating margins and positive EBITDA, indicating core manufacturing economics and cost structures that can support ongoing operations and incremental investment. This underpins cash flow potential if stabilized.
Bears Say
Material Margin CompressionMargins have materially compressed from FY2021 levels, reflecting weaker pricing, mix shifts, or higher input costs. Sustained lower gross and net margins reduce earnings power, constrain reinvestment capacity, and make returns sensitive to raw material or pricing volatility over the medium term.
Weak, Volatile Free Cash FlowInconsistent free cash flow generation and low operating cash conversion versus net income limit the company's ability to self-fund growth, pay down debt, or return capital. Volatile FCF increases reliance on external financing for investments and reduces margin for error in slower periods.
Normalized/declining Returns On EquityROE has normalized sharply from prior peaks, signalling reduced profitability relative to capital employed. Lower returns on equity can constrain shareholder value creation and indicate the business faces structural pressures to restore prior earnings intensity over the medium term.
IOL Chemicals & Pharmaceuticals Ltd. News
IOLCP FAQ
What was IOL Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
IOL Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹67.14 and its highest was ₹151.05 in the past 12 months.
What is IOL Chemicals & Pharmaceuticals Ltd.’s market cap?
IOL Chemicals & Pharmaceuticals Ltd.’s market cap is ₹41.99B.
When is IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 33 days.
How were IOL Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
IOL Chemicals & Pharmaceuticals Ltd. released its earnings results on May 20, 2026. The company reported ₹1.8 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.8.
Is IOL Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts IOL Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does IOL Chemicals & Pharmaceuticals Ltd. pay dividends?
IOL Chemicals & Pharmaceuticals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.97%. See more information on IOL Chemicals & Pharmaceuticals Ltd. dividends here
What is IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IOL Chemicals & Pharmaceuticals Ltd. have?
IOL Chemicals & Pharmaceuticals Ltd. has 293,527,500 shares outstanding.
What happened to IOL Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
IOL Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹1.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.466%.
Which hedge fund is a major shareholder of IOL Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:IOLCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IOL Chemicals & Pharmaceuticals Ltd.
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
Technical Analysis
Aarti Drugs Limited
―
Granules India Limited
―
Hikal Limited
―
Neuland Laboratories Ltd.
―
Solara Active Pharma Sciences Ltd.
―